As of April 19, 2025, IO Biotech (IOBT) has a market cap of $56.664 million USD. According to our data, IO Biotech is ranked No.7985 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $56.66 M |
-6.51%
|
Dec 31, 2024 | $60.61 M |
-51.06%
|
Dec 29, 2023 | $0.12 B |
-18.26%
|
Dec 30, 2022 | $0.15 B |
-64.06%
|
Dec 31, 2021 | $0.42 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.74 B |
0.000 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() Inovio Pharmaceuticals
INO
|
$63.81 M |
0.000 M
|
![]() USA
|
![]() Curevac
CVAC
|
$0.70 B |
0.000 M
|
![]() Germany
|
![]() Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
![]() USA
|
![]() Arcturus Therapeutics
ARCT
|
$0.29 B |
0.000 M
|
![]() USA
|
![]() Vaxart
VXRT
|
$78.48 M |
0.890 M
|
![]() USA
|
![]() Dynavax Technologies
DVAX
|
$1.28 B |
0.000 M
|
![]() USA
|
![]() Telesis Bio
TBIO
|
$1.64 M |
0.000 M
|
![]() USA
|
![]() Altimmune
ALT
|
$0.35 B |
-0.000 M
|
![]() USA
|
![]() Agenus
AGEN
|
$52.64 M |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$61.27 M |
0.051 M
|
![]() UK
|
![]() Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
![]() USA
|
Market Cap | = | IOBT Stock Price | * | IOBT Shares Outstanding |
= | $0.86 | * | 65.88 M | |
= | $56.66 M |